GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CardieX Ltd (ASX:CDX) » Definitions » Return-on-Tangible-Asset

CardieX (ASX:CDX) Return-on-Tangible-Asset : 10.71% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is CardieX Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. CardieX's annualized Net Income for the quarter that ended in Dec. 2023 was A$1.61 Mil. CardieX's average total tangible assets for the quarter that ended in Dec. 2023 was A$15.07 Mil. Therefore, CardieX's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 10.71%.

The historical rank and industry rank for CardieX's Return-on-Tangible-Asset or its related term are showing as below:

ASX:CDX' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -145.5   Med: -57.32   Max: -27.21
Current: -64.49

During the past 13 years, CardieX's highest Return-on-Tangible-Asset was -27.21%. The lowest was -145.50%. And the median was -57.32%.

ASX:CDX's Return-on-Tangible-Asset is ranked worse than
81.16% of 865 companies
in the Medical Devices & Instruments industry
Industry Median: -2.68 vs ASX:CDX: -64.49

CardieX Return-on-Tangible-Asset Historical Data

The historical data trend for CardieX's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardieX Return-on-Tangible-Asset Chart

CardieX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.43 -27.91 -51.47 -102.74 -145.50

CardieX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -79.81 -99.50 -135.09 -148.45 10.71

Competitive Comparison of CardieX's Return-on-Tangible-Asset

For the Medical Devices subindustry, CardieX's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardieX's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CardieX's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where CardieX's Return-on-Tangible-Asset falls into.



CardieX Return-on-Tangible-Asset Calculation

CardieX's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-18.887/( (12.057+13.904)/ 2 )
=-18.887/12.9805
=-145.50 %

CardieX's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=1.614/( (13.904+16.241)/ 2 )
=1.614/15.0725
=10.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


CardieX  (ASX:CDX) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


CardieX Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of CardieX's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CardieX (ASX:CDX) Business Description

Traded in Other Exchanges
N/A
Address
55 Lime Street, Suite 301, Level 3, Sydney, NSW, AUS, 2000
CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.

CardieX (ASX:CDX) Headlines

No Headlines